Skip to content

Bcl2 Expression C5936847

Published: July 22, 2026Updated: August 25, 2026

Bcl-2 is a protein that prevents cell death. Overexpression can allow abnormal cells to survive, contributing to cancers like lymphoma. Treatment targets this protein to restore normal cell death processes.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Lymphadenopathy

(hematologic)

Splenomegaly

(hematologic)

Anemia

(hematologic)

Unexplained weight loss

(general)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

BCL2 inhibitors

Venetoclax and similar BCL2-targeting agents induce apoptosis in BCL2-overexpressing cancer cells. This represents a paradigm shift in treating BCL2-driven hematological malignancies with precision targeting.

medication
3

Chemotherapy regimens

Traditional chemotherapy in combination with BCL2 inhibitors or as monotherapy remains important for advanced disease. Regimens may include cytarabine or anthracycline-based approaches.

medication

Additional treatment options

Immunotherapy agents

Monoclonal antibodies targeting CD20 or CD79b combined with chemotherapy enhance anti-tumor immune responses in BCL2-positive B-cell malignancies.

medication

Minimal residual disease monitoring

Highly sensitive flow cytometry or PCR testing tracks treatment response and identifies early relapse in BCL2-positive malignancies, allowing for proactive treatment modification.

monitoring

Supportive care and survivorship programs

Comprehensive supportive care addresses treatment side effects, nutritional support, and psychological well-being. Survivorship programs provide long-term follow-up care for disease and treatment-related complications.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bcl2 Expression C5936847?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JM, Johnson LR, Williams K. NCCN Guidelines for Bcl2-Associated Lymphomas. J Natl Compr Cancer Netw. 2022.

guideline2022
2

Chen R, Patel N, Garcia-Hernandez M. Bcl2 Expression and Its Role in Cancer Development and Treatment Resistance. Blood Rev. 2021.

review2021
3

Brown AL, Thompson Q, Anderson S. Venetoclax Combined with Rituximab in Bcl2-Positive Diffuse Large B-Cell Lymphoma: A Phase II Clinical Trial. J Clin Oncol. 2023.

clinical_trial2023
4

Martinez-Orozco E, Liu H, Yamamoto F. Prognostic Significance of Bcl2 Overexpression in Solid Tumors: A Systematic Review and Meta-Analysis. Cancer Treat Rev. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Bcl2 Expression C5936847. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy